MacroGenics, Inc. (MGNX) vs Niagen Bioscience Inc (NAGE)
A side-by-side comparison of MacroGenics, Inc. and Niagen Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGNX
MacroGenics, Inc.
$3.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NAGE
Niagen Bioscience Inc
$2.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MGNX vs NAGE
growth of $100 · dividends reinvested · last 10yMGNX -87.5% (-18.7%/yr)NAGE -10.1% (-1.1%/yr)NAGE compounded faster over this window
Log scale — wide-divergence pair
MGNX NAGE
MGNX vs NAGE: by the numbers
- •MGNX is the larger company ($231M vs $214M market cap).
- •NAGE is profitable (12.39% net margin) while MGNX runs a net loss (-8.70%).
- •NAGE grew revenue faster over the past five years (15.80% vs 7.33% CAGR).
Metrics side by side
Valuation
| Metric | MGNX | NAGE |
|---|---|---|
| P/E ratio | N/A | 14.43 |
| Forward P/E | N/A | 18.65 |
| P/S ratio | 1.38 | 1.66 |
| P/B ratio | 5.40 | 2.60 |
| EV / EBITDA | N/A | 14.36 |
| FCF yield | N/A | 2.65% |
Profitability
| Metric | MGNX | NAGE |
|---|---|---|
| Gross margin | 71.12% | 64.24% |
| Operating margin | -48.72% | 6.67% |
| Net margin | -8.70% | 12.39% |
| ROE | -34.04% | 19.38% |
| ROIC | -16.87% | 8.84% |
Growth (annualized)
| Metric | MGNX | NAGE |
|---|---|---|
| Revenue CAGR (5Y) | 7.33% | 15.80% |
| Total return CAGR (5Y) | -28.42% | -15.72% |
Frequently asked
- Which has grown faster, MGNX or NAGE?
- Over the past five years, NAGE grew revenue faster — MGNX at a 7.33% CAGR versus NAGE at 15.80%.
- Is MGNX or NAGE more profitable?
- NAGE runs the higher net margin — MGNX at -8.70% versus NAGE at 12.39%.
- How have MGNX and NAGE total returns compared?
- Over the past 10 years, MGNX delivered -18.75% and NAGE delivered -1.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Niagen Bioscience P/E ratioMacroGenics ROENiagen Bioscience ROEMacroGenics operating marginNiagen Bioscience operating marginMacroGenics revenue growthNiagen Bioscience revenue growthMacroGenics free cash flowNiagen Bioscience free cash flow
MacroGenics & Niagen Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.